Back to
HHLR Advisors, Ltd.
NXTC
Showing 0 of 9 quarters
Position history for
HHLR Advisors, Ltd.'s holdings in NextCure, Inc.
No. HHLR Advisors exited its NXTC (NextCure) position in Q2 2021. Its Q1 2021 13F listed 563,907 shares worth $5.6M. HHLR Advisors first reported NXTC in Q2 2019 and held it in 8 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.